Hao Z - Search Results

1

Development and validation of a novel prognostic lncRNA signature based on the APOBEC3 family genes in gastric cancer.

Qi J, Wu W, Chen J, Han X, Hao Z, Han Y, Xu Y, Lai J, Chen J. Qi J, et al. Among authors: hao z. Heliyon. 2024 Mar 17;10(6):e28307. doi: 10.1016/j.heliyon.2024.e28307. eCollection 2024 Mar 30. Heliyon. 2024. PMID: 38560679 Free PMC article.

2

Inflammatory dendritic cells restrain CD11b⁺CD4⁺ CTLs via CD200R in human NSCLC.

Lin M, Chen D, Shao Z, Liu Q, Hao Z, Xin Z, Chen Y, Wu W, Chen X, He T, Wu D, Wu P. Lin M, et al. Among authors: hao z. Cell Rep. 2024 Feb 27;43(2):113767. doi: 10.1016/j.celrep.2024.113767. Epub 2024 Feb 13. Cell Rep. 2024. PMID: 38354085 Free article.

3

JAML promotes the antitumor role of tumor-resident CD8⁺ T cells by facilitating their innate-like function in human lung cancer.

Hao Z, Xin Z, Chen Y, Shao Z, Lin W, Wu W, Lin M, Liu Q, Chen D, Wu D, Wu P. Hao Z, et al. Cancer Lett. 2024 May 28;590:216839. doi: 10.1016/j.canlet.2024.216839. Epub 2024 Apr 1. Cancer Lett. 2024. PMID: 38570084

4

NMI: a potential biomarker for tumor prognosis and immunotherapy.

He T, Qiao Y, Yang Q, Chen J, Chen Y, Chen X, Hao Z, Lin M, Shao Z, Wu P, Xu F. He T, et al. Among authors: hao z. Front Pharmacol. 2022 Nov 23;13:1047463. doi: 10.3389/fphar.2022.1047463. eCollection 2022. Front Pharmacol. 2022. PMID: 36506566 Free PMC article.

5

Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer.

Hao Z, Lin M, Du F, Xin Z, Wu D, Yu Q, Wu Y, Zhu Z, Li W, Chen Y, Chen X, Chai Y, Jin S, Wu P. Hao Z, et al. Front Immunol. 2022 Jan 18;12:754138. doi: 10.3389/fimmu.2021.754138. eCollection 2021. Front Immunol. 2022. PMID: 35116020 Free PMC article.

6

Oncolytic adenovirus promotes vascular normalization and nonclassical tertiary lymphoid structure formation through STING-mediated DC activation.

He T, Hao Z, Lin M, Xin Z, Chen Y, Ouyang W, Yang Q, Chen X, Zhou H, Zhang W, Wu P, Xu F. He T, et al. Among authors: hao z. Oncoimmunology. 2022 Jul 1;11(1):2093054. doi: 10.1080/2162402X.2022.2093054. eCollection 2022. Oncoimmunology. 2022. PMID: 35800155 Free PMC article.

7

CD38 identifies pre-activated CD8+ T cells which can be reinvigorated by anti-PD-1 blockade in human lung cancer.

Wu P, Zhao L, Chen Y, Xin Z, Lin M, Hao Z, Chen X, Chen D, Wu D, Chai Y. Wu P, et al. Among authors: hao z. Cancer Immunol Immunother. 2021 Dec;70(12):3603-3616. doi: 10.1007/s00262-021-02949-w. Epub 2021 May 2. Cancer Immunol Immunother. 2021. PMID: 33934206 Free PMC article.

8

Tissue-resident CD69⁺ CXCR6⁺ Natural Killer cells with exhausted phenotype accumulate in human non-small cell lung cancer.

Chen X, Chen Y, Xin Z, Lin M, Hao Z, Chen D, He T, Zhao L, Wu D, Wu P, Chai Y. Chen X, et al. Among authors: hao z. Eur J Immunol. 2022 Dec;52(12):1993-2005. doi: 10.1002/eji.202149608. Epub 2022 Nov 11. Eur J Immunol. 2022. PMID: 36205624 Free PMC article.

9

Epithelium/imcDC2 axis facilitates the resistance of neoadjuvant anti-PD-1 in human NSCLC.

Chen Y, Shao Z, Hao Z, Xin Z, Chen X, Huang L, Chen D, Lin M, Liu Q, Xu X, Li J, Wu D, Yan J, Chai Y, Wu P. Chen Y, et al. Among authors: hao z. J Immunother Cancer. 2024 Aug 12;12(8):e007854. doi: 10.1136/jitc-2023-007854. J Immunother Cancer. 2024. PMID: 39134346 Free PMC article. Clinical Trial.

10

The immune landscape of human thymic epithelial tumors.

Xin Z, Lin M, Hao Z, Chen D, Chen Y, Chen X, Xu X, Li J, Wu D, Chai Y, Wu P. Xin Z, et al. Among authors: hao z. Nat Commun. 2022 Sep 17;13(1):5463. doi: 10.1038/s41467-022-33170-7. Nat Commun. 2022. PMID: 36115836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,819 results

Search Page

Filters